Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CLDX

Celldex

$0.76

-1.395 (-64.73%)

07:13
04/17/18
04/17
07:13
04/17/18
07:13
Downgrade
Celldex rating change at Cantor Fitzgerald »

Celldex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDX

Celldex

$0.76

-1.395 (-64.73%)

05:53
04/17/18
04/17
05:53
04/17/18
05:53
Downgrade
Celldex rating change at Cantor Fitzgerald »

Celldex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Monday
CLDX

Celldex

$2.15

-0.09 (-4.02%)

13:02
04/16/18
04/16
13:02
04/16/18
13:02
Downgrade
Celldex rating change at Cowen »

Celldex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

CLDX

Celldex

$2.15

-0.09 (-4.02%)

10:57
04/16/18
04/16
10:57
04/16/18
10:57
Recommendations
Celldex analyst commentary at H.C. Wainwright »

Celldex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

CLDX

Celldex

$2.15

-0.09 (-4.02%)

08:10
04/16/18
04/16
08:10
04/16/18
08:10
Conference/Events
Celldex to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDX

Celldex

$2.15

-0.09 (-4.02%)

07:13
04/16/18
04/16
07:13
04/16/18
07:13
Hot Stocks
Celldex Phase 2b METRIC Study did not meet primary endpoint »

Celldex Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CBS

CBS

$52.18

-0.48 (-0.91%)

, CLDX

Celldex

$2.82

0.07 (2.55%)

07:30
03/12/18
03/12
07:30
03/12/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

CBS

CBS

$52.18

-0.48 (-0.91%)

CLDX

Celldex

$2.82

0.07 (2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDX

Celldex

$2.75

0.28 (11.34%)

10:50
03/09/18
03/09
10:50
03/09/18
10:50
Options
In the money put buyer opens a notable new position in Celldex Therapeutics »

In the money put buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSG

Inseego

$1.94

0.04 (2.11%)

, CMTL

Comtech

$24.27

0.3 (1.25%)

17:25
03/07/18
03/07
17:25
03/07/18
17:25
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

INSG

Inseego

$1.94

0.04 (2.11%)

CMTL

Comtech

$24.27

0.3 (1.25%)

CZR

Caesars

$12.50

0.15 (1.21%)

CLDX

Celldex

$2.47

0.06 (2.49%)

THO

Thor Industries

$122.41

0.8 (0.66%)

DVN

Devon Energy

$30.95

-0.38 (-1.21%)

ZAGG

Zagg

$15.50

0.35 (2.31%)

HDSN

Hudson Technologies

$6.17

0.02 (0.33%)

VKTX

Viking Therapeutics

$6.00

-0.06 (-0.99%)

GWRE

Guidewire

$91.17

5.94 (6.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 07

    Mar

  • 07

    Mar

  • 07

    Mar

  • 07

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 09

    Mar

  • 11

    Mar

  • 19

    Mar

  • 21

    Mar

  • 28

    Mar

  • 23

    May

  • 09

    Mar

CLDX

Celldex

$2.47

0.06 (2.49%)

16:08
03/07/18
03/07
16:08
03/07/18
16:08
Hot Stocks
Celldex believes has cash on hand to operate through 2019 »

Celldex believes that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.